www.fdanews.com/articles/150487-tonix-pk-study-confirms-effectiveness-of-tnx-102-sublingual-tablet

Tonix PK Study Confirms Effectiveness of TNX-102 Sublingual Tablet

October 25, 2012

Tonix Pharmaceuticals has completed dosing and plasma analysis of a pharmacokinetic (PK) study of its TNX-102 sublingual tablet, a formulation of cyclobenzaprine for bedtime use.
Pharmaceutical Business Review